Emerging Technologies | Medical
Virotherapy is a type of cancer treatment that uses viruses to kill cancer cells. Viruses are injected into the body, where they target and kill cancer cells. This treatment is still in the early stages of development, and more research is needed to determine its effectiveness.
Some of the emerging trends in virotherapy include the use of oncolytic viruses for cancer treatment, the use of viruses for the delivery of gene therapy vectors, and the use of viruses for the treatment of infectious diseases.
See live data on companies, R&D, markets, and news
In order to access the link, you need a Mergeflow account.
Frequently asked questions about the trial
How does the trial work?
After you sign up, you'll receive an email from us with an account activation link. Over the course of the trial, we'll send you emails with tips and tricks. The trial ends automatically after 14 days. No further obligations on your part.
Does the trial include all features?
The trial includes all Analyst Plan features.
Will I be charged when my trial is up?
No. We do not ask for your credit card up front, so you will only be charged when you decide to buy a subscription.
Do I have to install anything?
No. Mergeflow is a SaaS software that runs in any modern web browser. And because it's a subscription, you get constant product updates.
Which payment options does Mergeflow offer?
You can pay your Innovator or Analyst subscription via credit card (American Express, MasterCard, Visa) or SEPA Direct Debits. The larger team plans, API and enterprise solutions can be paid via invoicing and bank transfer.
Does Mergeflow keep my data private?
Yes. We don't serve ads, we never sell anything you give us, and we protect your privacy.